A Study of Tirzepatide in Participants With Impaired Liver Function

NCT03940742 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Insufficiency

Interventions

DRUG: Tirzepatide

Sponsor

Eli Lilly and Company